Metabolic dysfunction-associated steatotic liver disease (MASLD) has emerged as the most
common chronic liver disease globally, affecting more than a third of the world's adult …

Nonalcoholic fatty liver disease (NAFLD) has become a leading cause of chronic liver
diseases globally. NAFLD includes a range of hepatic manifestations, starting with liver …

Obesity, type 2 diabetes, and non-alcoholic fatty liver disease (NAFLD) are characterized by
the concepts of lipo-and glucotoxicity. NAFLD is characterized by the accumulation of …

Metabolism-related fatty liver disease (MAFLD) is the most common form of chronic liver
disease in the world. Its pathogenesis is influenced by both environmental and genetic …

The prevalence of nonalcoholic steatohepatitis (NASH) is increasing rapidly worldwide, and
NASH has become a serious problem for human health. Recently, the selective activation of …

Background It is generally believed that complement system is strongly associated with the
risk of nonalcoholic fatty liver disease (NAFLD). However, complement system contains a …

Context Although cognitive impairment in nonalcoholic fatty liver disease (NAFLD) has
received attention in recent years, little is known about detailed cognitive functions in …

Metabolic-associated fatty liver disease (MAFLD) is one of the most common chronic liver
diseases, which in turn triggers mild inflammation, metabolic dysfunction, fibrosis, and even …

Background: This observational cross-sectional study was designed to explore the effects of
a low-carbohydrate diet (LCD) and a low-fat diet (LFD) on metabolic-dysfunction-associated …

Background The prevalence of metabolic associated fatty liver disease (MAFLD) presented
a booming growth over recent years in the whole world. MAFLD was associated with a …